Endoscopic treatment of primary vesicoureteral reflux in children with two different bulking agents, high success and low complication rates: comparison of Dexell and Vantris

DOĞAN, AHMET; ÖZKAN, KERAMETTİN; Guler, A.; Karakaya, A.

doi:10.1016/j.acuro.2.070.10.013

Endoscopic treatment of primary vesicoureteral reflux in children with two different bulking agents, high success and low complication rates: comparison of Dexell and Vantris

DOĞAN A. B., ÖZKAN K. U., Guler A. G., Karakaya A. E.

ACTAS UROLOGICAS ESPANOLAS, cilt.45, sa.8, ss.545-551, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 45 Sayı: 8
Basım Tarihi: 2021
Doi Numarası: 10.1016/j.acuro.2.070.10.013
Dergi Adı: ACTAS UROLOGICAS ESPANOLAS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, Gender Studies Database, MEDLINE, DIALNET
Sayfa Sayıları: ss.545-551
Anahtar Kelimeler: Vesicoureteral reflux, Dextranomer hyaluronic acid, Polyacrylate-polyalcohol copolymer, Vesicoureteral obstruction
Erciyes Üniversitesi Adresli: Evet

Özet

Introduction and Objectives: To compare the results in terms of efficacy and safety of the endoscopic management for vesicoureterat reflux (VUR) in two different standardized primary VUR cohorts treated with Dexell and Vantris.